Catalyst
Slingshot members are tracking this event:
Presentation of ProQR's(PRQR) QR-421a Program in Ophthalmology Expected at Usher Syndrome Coalition Conference in July
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PRQR | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 13, 2019
Occurred Source:
https://www.proqr.com/wp-content/uploads/2018/09/ProQR_QR-421a-an-antisense-oligonucleotide-for-the-treatment-of-RP-due-to-USH2A-exon-13-mutations.pdf
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ophthalmics, Qr-421a
